Towards a Structural View of Drug Binding to hERG K + Channels
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 38 (10) , 899-907
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council (DP150101929)
- National Health and Medical Research Council (App1074386)
- NSW Department of Health
- National Institutes of Health (R01-GM057846)
- Membrane Protein Structural Dynamics Consortium (GM087519)
This publication has 47 references indexed in Scilit:
- Cryo-EM Structure of the Open Human Ether-à-go-go -Related K + Channel hERGCell, 2017
- The Future of Arrhythmias and ElectrophysiologyCirculation, 2016
- A Primer to Single-Particle Cryo-Electron MicroscopyCell, 2015
- Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research ConsortiumAmerican Heart Journal, 2014
- hERG K+Channels: Structure, Function, and Clinical SignificancePhysiological Reviews, 2012
- The hERG K+ channel: target and antitarget strategies in drug developmentPharmacological Research, 2008
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel FamilyScience, 1995
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995
- Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.Journal of General Physiology, 1990